Poster
Sabrine Nasfi
Institute for Phytopathology, Justus Liebig University
Giessen, Hessen, Germany
Bernhard Timo Werner
Postdoctoral researcher
Justus Liebig University Giessen, Institute of Phytopathology
Giessen, Hessen, Germany
Jens Steinbrenner
IFZ- Phytopathology institute
Giessen, Hessen, Germany
Lienhard Schmitz
Institute of biochemistry, Medical Faculty
Giessen, Hessen, Germany
Manar Makhoul
Departement of Plant breeding, Research center for biosystems, land use and nutrition
Giessen, Hessen, Germany
Patrick Schäfer
Justus Liebig University Giessen, Institute of Phytopathology
Giessen, Hessen, Germany
RNA interference (RNAi) regulates gene expression through small regulatory RNA (sRNA)-guided cleavage of target mRNAs. Targeting pathogen mRNA with sRNAs provides a promising strategy for plant disease control; however, accurate degradome analysis remains challenging. Existing methods (e.g. PARE, RLM-RACE) are labor-intensive, low in sensitivity, and lack quantitative precision. We therefore developed Native Index Ligation-based Targeted Degradome Sequencing (NIL-TDS), a novel, cost-effective Oxford Nanopore sequencing (ONT)-based method for direct, high-resolution detection and quantification of sRNA-guided cleavage events. As a proof of concept, NIL-TDS was applied on heat and salt-stressed plants, analysing Ath-miR400 and its target PENTATRICOPEPTIDE REPEAT 1 (PPR1). Quantitative data confirmed the presumed stress-mediated reduction in PPR1 cleavage for the first time, demonstrating NIL-TDS´s suitability for accurate prediction and selection of small RNAs. This approach refines degradome analyses thereby streamlining the discovery and validation of naturally occurring silencing events in plant-microbe-interactions and facilitating the development of RNA-based crop protection strategies. NIL-TDS application extends beyond plants and is demonstrated by detecting rare slicing events in mammals, such as miR-196-HOXB8 interactions in lung cancer cells. These findings highlight NIL-TDS’s potential to uncover novel regulatory mechanisms in gene expression and disease progression.